© The Institution of Engineering and Technology
The optical and physico-chemical properties of gold nanoparticles (AuNPs) have prompted new and improved approaches which have greatly evolved the fields of biosensing and molecular detection. In this study, the authors took advantage of AuNPs’ ease of modification and functionalised it with selected DNA aptamers using a salt aging method to produce gold-aptamer nanoprobes. After characterisation, these nanoprobes were subsequently used for biomolecular detection of glycidamide (GA)–guanine (Gua) adducts generated in vitro. The results are based on differences in nanoprobe stabilisation against salt-induced aggregation, similar to the non-cross-linking method developed by Baptista for discrimination of specific sequences. Alkylated Guas were efficiently discriminated from deoxyguanosine and GA in solution. Despite this, a clear identification of DNA adducts derived from genomic DNA alkylation has proven to be a more challenging task.
References
-
-
1)
-
26. Sen, A., Ozgun, O., Arinç, E., Arslan, S.: ‘Diverse action of acrylamide on cytochrome P450 and glutathione S-transferase isozyme activities, mRNA levels and protein levels in human hepatocarcinoma cells’, Cell Biol. Toxicol., 2012, 28, pp. 175–186 (doi: 10.1007/s10565-012-9214-1).
-
2)
-
21. Martins, C., Oliveira, N.G., Pingarilho, M., et al: ‘Cytogenetic damage induced by acrylamide and glycidamide in mammalian cells: correlation with specific glycidamide-DNA adducts’, Toxicol. Sci., 2007, 95, pp. 383–390 (doi: 10.1093/toxsci/kfl155).
-
3)
-
25. Camacho, L., Latendresse, J.R., Muskhelishvili, L., et al: ‘Effects of acrylamide exposure on serum hormones, gene expression, cell proliferation, and histopathology in male reproductive tissues of Fischer 344 rats’, Toxicol. Lett., 2012, 211, pp. 135–143 (doi: 10.1016/j.toxlet.2012.03.007).
-
4)
-
19. Carere, A.: ‘Genotoxicity and carcinogenicity of acrylamide: a critical review’, Ann. Ist Super Sanita, 2006, 42, pp. 144–155.
-
5)
-
2. Baptista, P., Pereira, E., Eaton, P., et al: ‘Gold nanoparticles for the development of clinical diagnosis methods’, Anal. Bioanal. Chem., 2008, 391, pp. 943–950 (doi: 10.1007/s00216-007-1768-z).
-
6)
-
30. Baptista, P., Doria, G., Henriques, D., et al: ‘Colorimetric detection of eukaryotic gene expression with DNA-derivatized gold nanoparticles’, J. Biotechnol., 2005, 119, (2), pp. 111–117 (doi: 10.1016/j.jbiotec.2005.02.019).
-
7)
-
30. Zadeh, J.N., Steenberg, C.D., Bois, J.S., et al: ‘NUPACK: analysis and design of nucleic acid systems’, J. Comput. Chem., 2011, 32, pp. 170–173 (doi: 10.1002/jcc.21596).
-
8)
-
23. Besaratinia, A., Pfeifer, G.P.: ‘Genotoxicity of acrylamide and glycidamide’, J. Natl. Cancer Inst., 2004, 96, pp. 1023–1029 (doi: 10.1093/jnci/djh186).
-
9)
-
14. Wang, Y., Liu, B.: ‘ATP detection using a label-free DNA aptamer and a cationic tetrahedralfluorene’, Analyst, 2008, 133, pp. 1593–1598 (doi: 10.1039/b806908e).
-
10)
-
20. Settels, E., Bernauer, U., Palavinskas, R., Klaffke, H.S., Gundert-Remy, U., Appel, K.E.: ‘Human CYP2E1 mediates the formation of glycidamide from acrylamide’, Arch. Toxicol., 2008, pp. 717–727 (doi: 10.1007/s00204-008-0296-8).
-
11)
-
18. Kiga, D., Futamura, Y., Sakamoto, K., Yokoyama, S.: ‘An RNA aptamer to the xanthine/guanine base with a distinctive mode of purine recognition’, Nucleic Acids Res., 1998, 26, pp. 1755–1760 (doi: 10.1093/nar/26.7.1755).
-
12)
-
29. Nagy, E., Cornelius, M.G., Moller, L.: ‘Accelerated 32P-HPLC for bulky DNA adducts’, Mutagenesis, 2009, 24, (2), pp. 183–189 (doi: 10.1093/mutage/gen070).
-
13)
-
8. Rosa, J.P., Lima, J.C., Baptista, P.V.: ‘Experimental photophysical characterization of fluorophores in the vicinity of gold nanoparticles’, Nanotechnology, 2011, 22, p. 415202 (doi: 10.1088/0957-4484/22/41/415202).
-
14)
-
C.A. Mirkin ,
R.L. Letsinger ,
R.C. Mucic ,
J.J. Storhoff
.
Biological synthesis of triangular gold nanoprisms.
Nature
-
15)
-
24. Cavalieri, E., Saeed, M., Zahid, M., et al: ‘Mechanism of DNA depurination by carcinogens in relation to cancer initiation’, IUBMB Life, 2012, 64, pp. 169–179 (doi: 10.1002/iub.586).
-
16)
-
18. Thaxton, C.S., Georganopoulou, D.G., Mirkin, C.A.: ‘Gold nanoparticle probes for the detection of nucleic acid targets’, Clin. Chim. Acta, 2006, 363, (1–2), pp. 120–126 (doi: 10.1016/j.cccn.2005.05.042).
-
17)
-
22. Watzek, N., Böhm, N., Feld, J., et al: ‘N7-glycidamide-guanine DNA adduct formation by orally ingested acrylamide in rats: a dose-response study encompassing human diet-related exposure levels’, Chem. Res. Toxicol., 2012, 25, pp. 381–390 (doi: 10.1021/tx200446z).
-
18)
-
15. Zhang, X., Zhu, S., Deng, C., Zhang, X.: ‘Highly sensitive thrombin detection by matrix assisted laser desorption ionization-time of flight mass spectrometry with aptamer functionalized core–shell Fe₃O₄@C@Au magnetic microspheres’, Talanta, 2012, 88, pp. 295–302 (doi: 10.1016/j.talanta.2011.10.044).
-
19)
-
10. Zhang, J., Liu, B., Liu, H., Zhang, X., Tan, W.: ‘Aptamer-conjugated gold nanoparticles for bioanalysis’, Nanomedicine, 2013, 8, pp. 983–993 (doi: 10.2217/nnm.13.80).
-
20)
-
13. Tuerk, C., Gold, L.: ‘Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase’, Science, 1990, 249, pp. 505–510 (doi: 10.1126/science.2200121).
-
21)
-
P.K. Jain ,
K.S. Lee ,
I.H. El-Sayed ,
M.A. El-Sayed
.
Calculated absorption and scattering properties of gold nanoparticle of different size, shape, and composition: applications in biological imaging and biomedicine.
J. Phys. Chem. B
,
14 ,
7238 -
7248
-
22)
-
28. Gupta, R.C.: ‘Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen: DNA adducts’, Cancer Res., 1985, 45, p. 5656.
-
23)
-
1. Larguinho, M., Baptista, P.V.: ‘Gold and silver nanoparticles for clinical diagnostics – from genomics to proteomics’, J. Proteomics, 2012, 75, pp. 2811–2823 (doi: 10.1016/j.jprot.2011.11.007).
-
24)
-
16. Wang, W., Chen, C., Qian, M., Zhao, X.S.: ‘Aptamer biosensor for protein detection using gold nanoparticles’, Anal. Biochem., 2008, 373, pp. 213–219 (doi: 10.1016/j.ab.2007.11.013).
-
25)
-
9. Chen, S.J., Huang, Y.F., Huang, C.C., Lee, K.H., Lin, Z.H., Chang, H.T.: ‘Colorimetric determination of urinary adenosine using aptamer-modified gold nanoparticles’, Biosens. Bioelectron., 2008, 23, pp. 1749–1753 (doi: 10.1016/j.bios.2008.02.008).
-
26)
-
11. Mairal, T., Ozalp, V.C., Lozano Sánchez, P., et al: ‘Aptamers: molecular tools for analytical applications’, Anal. Bioanal. Chem., 2008, 390, pp. 989–1007 (doi: 10.1007/s00216-007-1346-4).
-
27)
-
17. Huang, Y.F., Chang, H.T.: ‘Analysis of adenosine triphosphate and glutathione through gold nanoparticles assisted laser desorption/ionization mass spectrometry’, Anal. Chem., 2007, 79, pp. 4852–4859 (doi: 10.1021/ac070023x).
-
28)
-
6. Veigas, B., Jacob, J.M., Costa, M.N., et al: ‘Gold on paper–paper platform for Au-nanoprobe TB detection’, Lab Chip, 2012, 12, pp. 4802–4808 (doi: 10.1039/c2lc40739f).
-
29)
-
17. Ellington, A.D., Szostak, J.W.: ‘In vitro selection of RNA molecules that bind specific ligands’, Nature, 1990, 346, (6287), pp. 818–822 (doi: 10.1038/346818a0).
-
30)
-
31. Conde, J., de la Fuente, J.M., Baptista, P.V.: ‘RNA quantification using gold nanoprobes - application to cancer diagnostics’, J. Nanobiotechnol., 2011, 8, p. 5 (doi: 10.1186/1477-3155-8-5).
-
31)
-
21. Doria, G., Franco, R., Baptista, P.: ‘Nanodiagnostics: fast colorimetric method for single nucleotide polymorphism/mutation detection’, IET Nanobiotechnol., 2007, 1, (4), pp. 53–57 (doi: 10.1049/iet-nbt:20070001).
-
32)
-
27. Coldwell, K.E., Cutts, S.M., Ognibene, T.J., Henderson, P.T., Phillips, D.R.: ‘Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations’, Nucl. Acids Res., 2008, 36, (16), p. e100 (doi: 10.1093/nar/gkn439).
http://iet.metastore.ingenta.com/content/journals/10.1049/iet-nbt.2014.0007
Related content
content/journals/10.1049/iet-nbt.2014.0007
pub_keyword,iet_inspecKeyword,pub_concept
6
6